Click here to see our Global Presence
Choose a country ... bioMérieux Argentina bioMérieux Australia bioMérieux Brazil bioMérieux China bioMérieux France bioMérieux Germany bioMérieux India bioMérieux Italy bioMérieux Japan bioMérieux Mexico bioMérieux Poland bioMérieux Portugal bioMérieux Russia bioMérieux Spain bioMérieux Switzerland bioMérieux Turkey bioMérieux USA Other countries
bioMérieux provides diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety.
bioMérieux Pandemic Preparedness bioMérieux is contributing its expertise in infectious disease diagnostics to the global effort to address the Influenza A/H1N1 pandemic.
November 6, 2009 bioMérieux Launches a Molecular Diagnostic MRSA Test on its EasyQ® Automated Platform
June 30, 2009 bioMérieux Launches VIDAS® EBV, a New Test for the Diagnosis of Infectious Mononucleosis
May 19, 2009 bioMérieux Launches Molecular Biology Test, NucliSENS EasyQ® HIV-1 v2.0, for Improved Care of Patients with HIVNew test can be used with the first CE marked Dry Blood Spot sample collection technique for viral load monitoring, bringing testing to patients in remote locations
September 28-30, 2009 FMLA Roadshow at Biomedical Science Congress
09/11/2009 Infection 2009
